PRVA Earnings

PRVA reported its earnings on 2026-02-26, showcasing a revenue of against an estimate of 520.06M, resulting in a 0% surprise. The EPS was 0, surpassing the expected 0.04 by 0%. The stock experienced a 9.98% price change on the earnings day and a 4.94% change over the next five days, reflecting market reactions to the results.

Following PRVA's earnings announcement on 2026-02-26, the stock price moved by 9.98% on the day of the release. Over the subsequent five days, it saw a 4.94% change. Historically, PRVA's stock price tends to shift by an average of -1.55% in the 10 days leading up to earnings and -3.37% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate PRVA's annual revenue to reach 543.79M, while the EPS is projected at 0.06. These estimates reflect recent revisions, with revenue estimates revised upward by 0.43% and EPS estimates revised upward by 0.43% over the past three months, indicating analyst expectation in the company's performance.

The correlation between PRVA's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were revised upward by 0.43%, while EPS estimates moved revised upward by 0.43%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, PRVA's stock price typically moves by -1.55% in the 10 days before its earnings and -3.37% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of 0.06 and revenue of 543.79M.

The earnings call reveals strong financial metrics, optimistic guidance, and strategic acquisitions, like the Evolent ACO, likely to enhance future profitability. The company’s strategy to deploy capital for growth, coupled with raised guidance, indicates positive market sentiment. Despite some management evasiveness on specifics, the overall tone is confident, suggesting a stock price increase. Given the market cap of $2 billion, the reaction is expected to be moderately positive.